Dexmedetomidine dose required in children undergoing laparoscopic surgeries for post op pain relief

A COMPARATIVE STUDY OF DEXMEDETOMIDINE DOSES (0.5MCG/KG VS 1MCG/KG) AS AN ADJUVANT TO 0.25% BUPIVACAINE FOR ULTRASOUND-GUIDED TRANSVERSUS ABDOMINIS PLANE (TAP) BLOCK IN CHILDREN UNDERGOING LAPAROSCOPIC SURGERIES - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064397

Enrollment

Registered

2024-03-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: Transverse Abdominis Plane Block (TAP) Block: Details Add New 1 INTERVENTION Transverse Abdominis Plane Block (TAP) Block in children undergoing laparoscopic surgeries for post op pain

Eligibility

Inclusion criteria

Inclusion criteria: Paediatric patients aged 2 to 10 years. (b) Scheduled for laparoscopic surgeries. (c) Patients with written informed consent of parents

Exclusion criteria

Exclusion criteria: (a) Parental refusal to undergo the procedure. (b) Known allergy to the local anesthetic drug used in the procedure. (c) History of cardio vascular, respiratory disease and Hepatorenal insufficiency. (d) Presence of coagulopathies. (e) Patients taking Adrenoceptor agonist/ antagonist (f) Inability to comply with study requirements

Design outcomes

Primary

Measure	Time frame
To determine the difference of mean time to first rescue analgesia with 0.5mcg/kg and 1mcg/kg Dexmedetomidine in USG guided TAP Block for paediatric patients undergoing laparoscopic surgeries using CHEOPS pain scaleTimepoint: First 24 hours after surgery	—

Secondary

Measure	Time frame
The total number of analgesic doses given in 24hrs after TAP Block in post op periodTimepoint: Upto 24hrs in post op period	—

Countries

India

Contacts

Public ContactSARANYA V

Army Hospital R and R

rjv.nr1@gmail.com7757024594

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026